Uh oh—ABT’s ABSORB stent showing higher MACE rate than Xience in FDA post-marketing analysis: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm547256.htm